Sept 29 (Reuters) – Abivax SA: * ABIVAX ANNOUNCES ACCEPTANCE OF ADDITIONAL LATE-BREAKING ABSTRACT FROM THE ABTECT PHASE 3 INDUCTION TRIALS TO BE PRESENTED AT 2025 UNITED EUROPEAN GASTROENTEROLOGY (UEG) MEETING Source text: Further company coverage: ;))
(The article has been published through a syndicated feed. Except for the headline, the content has been published verbatim. Liability lies with original publisher.)
By Kurt Hall NEW YORK, July 2 (Reuters) - Fencing is up, streets are closed…
LONDON, July 2 (Reuters) - Kate, Britain's Princess of Wales, mingled with the crowds at…
LONDON, July 2 (Reuters) - Kate, Britain's Princess of Wales, mingled with the crowds at…
LONDON, July 2 (Reuters) - Kate, Britain's Princess of Wales, mingled with the crowds at…
LONDON, July 2 (Reuters) - British prosecutors on Thursday charged former UK pop star Paul…
LONDON, July 2 (Reuters) - British prosecutors on Thursday charged former UK pop star Paul…